Why Copenhagen?

1st January, 1970

Why Copenhagen?

According to the Copenhagen Government, Denmark is number two in the world for developing biotechnology and number one in Europe in number of clinical trials per capita, owing to a strong life science industry employing more than 40,000 people.

Medicon Valley is based on close collaboration between industry, academia and the public sector, and has Scandinavia’s best knowledge transfer between the public and the private sector, providing excellent R&D opportunities.

An Ernest and Young report in 2015 highlighted that Medicon Valley has the third largest commercial product pipeline in the EU. Products in this pipeline are seeking to combat, cancer, diabetes and metabolic diseases, neurological disorders alongside allergies and autoimmune diseases.

The MedTech industry turnover in greater Copenhagen is estimated at €6.7bn making this a hugely attractive location to meet and engage with new clients.


Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the

If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:

Paul Adams
+44 (0)20 7936 6948

Speaker opportunities

We identify and invite individuals we believe to be the best speakers in the market, if you think you can make a difference to the quality of our events please contact:

Chloe Roberts
E: Chloe.Roberts@arena-international.com
T: +44 (0)207 936 6822